Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 05/25 05:35:18 pm
102.74 EUR   +0.77%
07:47aUNITED STATES G : Genetically Modified Seeds Market: Regional Indust..
AQ
05/25GRAIN HIGHLIGHT : Top Stories of the Day
DJ
05/25LIVESTOCK HIGHL : Top Stories of the Day
DJ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Bayer Stops Sale of Glucose Meter Business

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/09/2013 | 12:07pm CEST

By Hendrik Varnholt

FRANKFURT--German pharmaceutical company Bayer AG (>> Bayer AG) will retain its blood glucose meter business, a spokeswoman said Wednesday, confirming a Bloomberg report.

Bayer had put up the unit for sale and had been in talks with French peer Sanofi SA (>> SANOFI) about a deal which could have been valued at around $1.5 billion, people familiar with the matter told Dow Jones Newswires in December.

"We have evaluated several options and decided to retain it," Bayer HealthCare chief Joerg Reinhardt said about the glucose meter business, according to Bloomberg.

Natali Schwab, Eyk Henning and Dana Cimilluca contributed to this story.

Write to Hendrik Varnholt at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Bayer AG, SANOFI
Stocks mentioned in the article
ChangeLast1st jan.
BAYER 0.77% 102.74 Delayed Quote.0.35%
SANOFI -0.18% 65.43 Delayed Quote.-9.13%
SANOFI 0.00% 65.78 Real-time Quote.-8.45%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
07:47aUNITED STATES GENETICALLY MODIFIED S : Genetically Modified Seeds Market: Region..
AQ
05/25GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
05/25LIVESTOCK HIGHLIGHTS : Top Stories of the Day
DJ
05/25Bayer cuts Monsanto synergy target by $300 million due to divestments
RE
05/25Saudi Arabia to exclude German firms from government tenders - Spiegel
RE
05/25BAYER : is making good progress strategically
PU
05/25Bayer Lowers Synergy Expectations From Monsanto Deal
DJ
05/24EXCLUSIVE - U.S. WANTS CHINA TO APPR : sources
RE
05/23BAYER : Monsanto deal gets approval of Competition Commission of India
AQ
05/23BAYER : SAM advises Monsanto on securing CCI approval Bayer AG
AQ
More news
News from SeekingAlpha
05/25BLOOMBERG : Bayer-Monsanto to win U.S. antitrust OK next week 
05/25MINING FOR ASCO 2018'S GOLD, PART 3 : Making Money In The Brain 
05/25Bayer cuts Monsanto earnings synergies outlook by $300M 
05/22Indian regulator approves Bayer's takeover of Monsanto 
05/19Spotlight On Gambling Reset And Banking Bill 
Financials (€)
Sales 2018 35 006 M
EBIT 2018 7 265 M
Net income 2018 5 121 M
Debt 2018 8 440 M
Yield 2018 2,76%
P/E ratio 2018 18,09
P/E ratio 2019 16,43
EV / Sales 2018 2,76x
EV / Sales 2019 2,48x
Capitalization 88 146 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 117 €
Spread / Average Target 14%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER0.35%102 690
JOHNSON & JOHNSON-11.45%325 801
PFIZER-0.91%208 713
NOVARTIS-8.30%194 397
ROCHE HOLDING LTD.-9.17%189 708
MERCK AND COMPANY5.01%158 970